NCT06218628 2024-05-03Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 InhibitionFox Chase Cancer CenterPhase 1 Recruiting24 enrolled
NCT01399840 2017-09-15Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological MalignanciesPfizerPhase 1 Completed33 enrolled